National Heart, Lung, and Blood Institute (NHLBI): Coronary Disease trials

The registry lists 213 Coronary Disease studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 2 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 16Phase 3 37No phase 159(a study in two phases counts in both)

Studies

Page 3 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Coronary Drug Project Mortality SurveillanceCompletedNCT00000483Not applicable
• Coronary Drug ProjectCompletedNCT00000482Phase 3
• Multicenter Unsustained Tachycardia Trial (MUSTT)CompletedNCT00000480Phase 3
• Asymptomatic Cardiac Ischemia Pilot (ACIP) StudyCompletedNCT00000478Phase 3
• Cholesterol Reduction in Seniors Program (CRISP)CompletedNCT00000477Phase 2
• Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?CompletedNCT00000473Phase 3
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)CompletedNCT00000472Phase 3
• Lifestyle Heart TrialCompletedNCT00000471Phase 2
• Postmenopausal Estrogen/Progestin Interventions (PEPI)CompletedNCT00000466Phase 3
• Emory Angioplasty Versus Surgery Trial (EAST)CompletedNCT00000465Phase 3
• Post Coronary Artery Bypass Graft (CABG) StudyCompletedNCT00000463Phase 3
• Bypass Angioplasty Revascularization Investigation (BARI)CompletedNCT00000462Phase 3
• Harvard Atherosclerosis Reversibility Project (HARP)CompletedNCT00000461Phase 2